Dosimetric Evaluation of Two Multileaf Collimator Systems in Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Stage IIIC Cervical Cancer with Lymph Node Metastases - Takeaways - MDSpire

Dosimetric Evaluation of Two Multileaf Collimator Systems in Simultaneous Integrated Boost Volumetric Modulated Arc Therapy for Stage IIIC Cervical Cancer with Lymph Node Metastases

  • By

  • Hui Xiao

  • Ang Qu

  • Haitao Sun

  • Xile Zhang

  • Nan Zhang

  • Shuhua Wei

  • Xiuwen Deng

  • Chunxiao Li

  • Junjie Wang

  • Ping Jiang

  • April 23, 2026

  • 0 min

Share

  • 1

    The study evaluated dosimetric performance of two multileaf collimator systems in SIB-VMAT for stage IIIC cervical cancer with lymph node metastases.

  • 2

    Both MLC systems achieved clinically acceptable target coverage across all lymph node metastasis subgroups in the study.

  • 3

    The α-MLC system showed improved dose gradient control for the planning target volume, particularly in bilateral pelvic lymph node metastases.

  • 4

    The α-MLC system consistently reduced doses to organs at risk compared to the p-MLC system, enhancing patient safety.

  • 5

    These findings may guide equipment selection and planning strategies in challenging nodal boost scenarios for advanced cervical cancer.

Original Source(s)

Related Content